Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:5/21/2020)... ST. PAUL, Minn. (PRWEB) , ... May 21, ... ... company, a medical device manufacturer, announces its first milestone to deliver over one ... in just eight weeks. Summit Medical Face Shields meet the critical need for ...
(Date:5/21/2020)... ... May 21, 2020 , ... Friends of Lisa Campbell, announce that ... by Planned Parenthood Southeast Advocates (PPSEA). PPSEA educates and lobbies on ... the full range of reproductive health care. PPSEA educates and lobbies on behalf of ...
(Date:5/21/2020)... ... May 21, 2020 , ... Casenet® LLC ... platform that supports care management and utilization management at health insurance plans. Developed ... TruCare 2020 provides significant usability and automation upgrades to all of its existing ...
(Date:5/16/2020)... ... ... to see Andy Gaertner, D.M.D , in the past, they will have seen the ... re-open during the current pandemic, they have put some new protocols in place. The goal ... going through their dental exams and treatments. , The new protocols that Dr. Gaertner has ...
(Date:5/15/2020)... ELGIN, Ill. (PRWEB) , ... May 15, 2020 , ... ... get back on their feet by making sure their employees can get back to ... so popular, they have expanded to gyms, restaurants, bars, and countless other settings. , ...
Breaking Medicine News(10 mins):
... HOUSTON - Patients with triple negative breast cancer that also ... lower risk of recurrence, compared to those with the same ... The University of Texas MD Anderson Cancer Center. The ... in this select group of triple negative breast cancer patients, ...
... HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... hormone may be an effective treatment for younger women ... delaying a total hysterectomy, which is the usual treatment ... fertile and possibly to have families, according to the ...
... , WEDNESDAY, Sept. 29 (HealthDay News) -- Driven by reports ... sleep positioners are dangerous and should not be used. ... and Drug Administration (FDA) and the U.S. Consumer Product Safety ... 12 babies under 4 months old suffocated in the ...
... Although first responders willingly put themselves in harm,s way during ... willing if the disaster is a potentially lethal pandemic. ... School of Public Health found that more than 50% of ... be absent from work during a serious pandemic, even if ...
... led by a Michigan State University scientist has been awarded ... young women, focusing on growth, diet, physical activity and body ... study, funded by the National Institutes of Health and led ... of Epidemiology, will include the largest sample in the United ...
... Indiana University Melvin and Bren Simon Cancer Center have ... changes in brain tissue can occur in breast cancer ... often referred to as "chemobrain," have been known for ... to use brain imaging to study women with breast ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products:
(Date:5/26/2020)... , ... May 26, 2020 , ... SignatureCare Emergency Center, ... of Pflugerville, TX . , The new ER is set to open early June, ... School Road at 21315 N SH 130, Bldg.4, Pflugerville, TX. , According to ...
(Date:5/26/2020)... ... May 26, 2020 , ... Rize Health, an ... to provide them with revolutionary clinical trial solutions. , Through this strategic partnership, ... solution that enables onboarding, scheduling, and remote data capture - right from your ...
(Date:5/25/2020)... SARASOTA, Fla. (PRWEB) , ... May 25, 2020 , ... ... OMMU ), continues its statewide expansion with a three-day, Memorial Day Opening, starting ... Trail in Bonita Springs. , During the opening, staggered over three-days for crowd mitigation, ...
Breaking Medicine Technology:
... ARAY ), a global leader in the field ... present at the 10th Annual Needham Healthcare Conference in New ... ET/7:00 a.m. PT. A live webcast of the ... of the Company,s Web site at http://www.accuray.com . The ...
... March 28, 2011 JHP Pharmaceuticals, a leading ... products, has entered into a multi-year contract-manufacturing agreement ... responsible for manufacturing and supply of a sterile ... Stuart Hinchen, president and co-founder of JHP noted, ...
Cached Medicine Technology: